Risk of serious COVID-19 infection can now be predicted
Researchers develop rapid test for severe infections
Researchers have developed a method for assessing the number and structure of aggregated blood platelets (or thrombocytes) that can potentially help quantify the risk of a severe Covid-19 infection. As a result, they have identified a predictive biomarker for the seriousness of a COVID-19 infection. This will allow physicians to adjust treatment at an early stage. The researchers used a method from image-based flow cytometry that permits the rapid analysis of interactions between large numbers of blood cells.
When infected with the Sars-CoV-2 virus, the human body produces a series of immune responses. One of them involves platelets, also known as thrombocytes, sticking to immune cells to form clumps, or aggregates, of cells in the bloodstream. In a study using image-based flow cytometry, a team of researchers working with Oliver Hayden, a professor of biomedical electronics, demonstrated a rapid rise in concentrations of platelet aggregates in patients admitted to intensive care with COVID-19 infections.
This enabled them to identify a biomarker for predicting the risk of severe illness in COVID-19 patients. The result was made possible by the optimal interdisciplinary conditions offered by the central TranslaTUM institute to TUM engineers for collaboration with medical researchers at Klinikum München rechts der Isar.
Proximity to patients and simple measurements
The analysis began with a blood sample taken from the test subjects. A few drops of blood are needed to count thousands of blood cells and their aggregates within seconds using image-based flow cytometry. The head of the study, Prof. Hayden, says: “Another big advantage of this method is that we neither have to treat nor mark the samples. Using standardized methods, we can investigate them directly without aggregation losses caused by high shearing forces. In the future, this cost-effective method could help quantify interactions between the coagulation system and the immune system.” The close proximity of patients to the lab when taking samples permits the blood to be tested immediately. This rules out effects from the aging of samples, which also causes aggregates to form.
Up to two-thirds of platelets in infected patients aggregated
The researchers investigated blood samples from 36 intensive care patients (age 32 to 83) admitted to the hospital with a SARS-CoV-2 infection classified as moderate to severe. The results showed that the number of aggregated thrombocytes in the blood samples of severely ill patients was significantly higher than in moderately ill patients and definitely in healthy blood donors.
With regard to the cell aggregates, the researchers found that the number of aggregates and their composition changed gradually in line with the severity of the COVID-19 infection and that these changes occurred at an early stage before complications appeared. The aggregates were typically made up of fewer than 10 thrombocytes. In extreme cases, it was observed that up to two thirds of all thrombocytes in a patient were aggregated.
Better patient management
A high concentration of cell aggregates was seen in all COVID-19 patients admitted to intensive care. This simple diagnostic method based on blood cell aggregates has the potential to identify high-risk patients at an early stage and improve their care.
The interdisciplinary team of engineers and medical researchers now plan to transfer what they have learned to other diseases. They believe that the method described here could also function with cardiovascular disease or cancers.
Original publication
Christian Klenk, Johanna Erber, David Fresacher, Stefan Röhrl, Manuel Lengl, Dominik Heim, Hedwig Irl, Martin Schlegel, Bernhard Haller, Tobias Lahmer, Klaus Diepold, Sebastian Rasch, Oliver Hayden; "Platelet aggregates detected using quantitative phase imaging associate with COVID-19 severity"; Communications Medicine, Volume 3, 2023-11-7
Other news from the department science
![[Fe]-hydrogenase catalysis visualized using para-hydrogen-enhanced nuclear magnetic resonance spectroscopy](https://img.chemie.de/Portal/News/675fd46b9b54f_sBuG8s4sS.png?tr=w-712,h-534,cm-extract,x-0,y-16:n-xl)
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.
Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.
